(RS)-3-[5-(Difluoromethyl)pyrazolo[1,5-a]pyrimidin-7-yl]-1-piperidyl]-(4,5,6,7-tetrahydrobenzothiophen-2-yl)methanone

ID: ALA4751598

Chembl Id: CHEMBL4751598

PubChem CID: 162653016

Max Phase: Preclinical

Molecular Formula: C21H22F2N4OS

Molecular Weight: 416.50

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1cc2c(s1)CCCC2)N1CCCC(c2cc(C(F)F)nc3ccnn23)C1

Standard InChI:  InChI=1S/C21H22F2N4OS/c22-20(23)15-11-16(27-19(25-15)7-8-24-27)14-5-3-9-26(12-14)21(28)18-10-13-4-1-2-6-17(13)29-18/h7-8,10-11,14,20H,1-6,9,12H2

Standard InChI Key:  NQOBCGNEXNXNCO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4751598

    ---

Associated Targets(Human)

PDE2A Tclin Phosphodiesterase 2A (1799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3B Tclin Phosphodiesterase 3B (312 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pde10a cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (1396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.50Molecular Weight (Monoisotopic): 416.1482AlogP: 4.63#Rotatable Bonds: 3
Polar Surface Area: 50.50Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.28CX LogP: 4.15CX LogD: 4.15
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.63Np Likeness Score: -2.16

References

1. Tresadern G,Velter I,Trabanco AA,Van den Keybus F,Macdonald GJ,Somers MVF,Vanhoof G,Leonard PM,Lamers MBAC,Van Roosbroeck YEM,Buijnsters PJJA.  (2020)  [1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration.,  63  (21.0): [PMID:33105987] [10.1021/acs.jmedchem.0c01272]

Source